ETF Expert Corner

Check out our archive of podcasts

Biotech Expert Brad Loncar on Cancer Immunotherapy, Biotech ETFs

Brad Loncar, biotech expert & CEO of Loncar Investments, discusses the latest in cancer immunotherapy and highlights the index behind the Loncar Cancer Immunotherapy ETF (CNCR).  Brad also offers insight into the broader biotech sector, including the three largest biotech ETFs.

Skip to content